Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2005; 10: 47–8
Computerised systems using instrumental biocommunication for treatment claim beneficial health effects. We set out a pilot study to test whether or not individuals treated with a programme called QUANTEC report improvements in well-being, health and fulfilment of pre-recorded wishes.
Thirty-four volunteers from the University Hospital Freiburg participated in the study. Before treatment, baseline measures were taken (self-report on wishes, well-being and health). Participants were then randomly and blindly allocated to two groups. In the first treatment phase of 3 months’ duration, only half of the participants were treated (group 1). At the end of the first treatment phase, post-treatment measures were taken. Participants were then unblinded as to group allocation and group 2 was treated. Finally, the second post-treatment measures were taken.
Data exploration revealed that individuals’ need for health improvement and blinding may be important psychological prerequisites for a treatment with instrumental biocommunication to be beneficial.
Treatments with QUANTEC may be accompanied by beneficial health effects. The latter do not necessarily bear on postulated causative mechanisms of treatments with instrumental biocommunication but might instead be purely psychological in nature. However, there are a number of limitations as to the quality and quantity of such effects, which calls for further investigation.
This study was supported by M-TEC AG, Altkirchen, Germany. RS and HW are employed by the Samueli Institute, Alexandria, VA, USA.
